» Articles » PMID: 20101207

The HTLV-1 Tax Protein Cooperates with Phosphorylated CREB, TORC2 and P300 to Activate CRE-dependent Cyclin D1 Transcription

Overview
Journal Oncogene
Date 2010 Jan 27
PMID 20101207
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Adult T-cell leukemia/lymphoma is a fatal malignancy etiologically linked to infection with the human T-cell leukemia virus (HTLV-1). The virally encoded oncoprotein Tax activates the transcription of HTLV-1 and cellular genes by cooperating with cellular transcription factors. Cyclin D1 is a pivotal regulator of cell cycle progression, and increased expression strongly correlates with malignant transformation. Here, we characterize the mechanism of Tax transactivation of cyclin D1. We find that cyclin D1 transcript levels are elevated in HTLV-1 infected cells and that Tax physically associates with the cyclin D1 gene in vivo. Tax binds the cyclin D1 promoter-proximal cyclic AMP response element (CRE) in the presence of phosphorylated CREB (pCREB) in vitro, and together the Tax-pCREB complex recruits the cellular co-activator p300 to the promoter through this unconventional Tax-responsive element. We further show that the transducer of regulated CREB 2 (TORC2) cooperates with Tax to further enhance p300 recruitment to the cyclin D1 promoter in vitro. Tax and TORC2 in combination stimulate cyclin D1 expression in vivo, demonstrating the functional outcome of the binding interactions. Together, our findings support a model in which Tax-induced accumulation of cyclin D1 shortens the G1 phase of the cell cycle, promotes mitotic replication of the virus, and drives selection and expansion of malignant T-cells.

Citing Articles

The role of CREB and MAPK signaling pathways in ATLL patients.

Akbarin M, Rezaee S, Farjami Z, Rahimi H, Rafatpanah H AIDS Res Ther. 2024; 21(1):81.

PMID: 39529101 PMC: 11552329. DOI: 10.1186/s12981-024-00664-x.


GPR137 Inhibits Cell Proliferation and Promotes Neuronal Differentiation in the Neuro2a Cells.

Iwasa K, Yamagishi A, Yamamoto S, Haruta C, Maruyama K, Yoshikawa K Neurochem Res. 2022; 48(3):996-1008.

PMID: 36436172 PMC: 9922245. DOI: 10.1007/s11064-022-03833-4.


The CREB Regulated Transcription Coactivator 2 Suppresses HIV-1 Transcription by Preventing RNA Pol II from Binding to HIV-1 LTR.

Ma L, Chen S, Wang Z, Guo S, Zhao J, Yi D Virol Sin. 2021; 36(4):796-809.

PMID: 33723808 PMC: 8379306. DOI: 10.1007/s12250-021-00363-1.


Effects of combined inhibition of STAT3 and VEGFR2 pathways on the radiosensitivity of non-small-cell lung cancer cells.

Hu C, Zhuang W, Qiao Y, Liu B, Liu L, Hui K Onco Targets Ther. 2019; 12:933-944.

PMID: 30774379 PMC: 6357889. DOI: 10.2147/OTT.S186559.


Adaptive Transcriptional Responses by CRTC Coactivators in Cancer.

Tasoulas J, Rodon L, Kaye F, Montminy M, Amelio A Trends Cancer. 2019; 5(2):111-127.

PMID: 30755304 PMC: 9682902. DOI: 10.1016/j.trecan.2018.12.002.


References
1.
Frank S, Schroeder M, Fernandez P, Taubert S, Amati B . Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 2001; 15(16):2069-82. PMC: 312758. DOI: 10.1101/gad.906601. View

2.
Screaton R, Conkright M, Katoh Y, Best J, Canettieri G, Jeffries S . The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell. 2004; 119(1):61-74. DOI: 10.1016/j.cell.2004.09.015. View

3.
Tashiro E, Tsuchiya A, Imoto M . Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci. 2007; 98(5):629-35. PMC: 11159462. DOI: 10.1111/j.1349-7006.2007.00449.x. View

4.
Matsuoka M, Jeang K . Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007; 7(4):270-80. DOI: 10.1038/nrc2111. View

5.
Conkright M, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch J . TORCs: transducers of regulated CREB activity. Mol Cell. 2003; 12(2):413-23. DOI: 10.1016/j.molcel.2003.08.013. View